natalizumab,fingolimod,ocrelizumab
biogen,novartis,roche
['natalizumab', 'fingolimod']
prof tomas kalincik ( , ) presents data at #ectrims2022 suggesting #ahsct is superior to fingolimod &amp; natalizumab in preventing relapses in people living with #multiplesclerosis. what does the future hold for stem cell transplants as a treatment option in #ms? 
Providing accurate, unbiased, easy to understand information about multiple sclerosis research and news worldwide. #MultipleSclerosis #MS